KBFS
NVO

Kohmann Bosshard Financial Services’s Novo Nordisk NVO Stock Holding History

Kohmann Bosshard Financial Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-246
Closed -$12.5K – 472
2025
Q4 		$12.5K Buy
+246
New +$12.6K ﹤0.01% 802
2025
Q1 		– Sell
-1,246
Closed -$107K – 622
2024
Q4 		$107K Buy
+1,246
New +$135K 0.01% 250

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Kohmann Bosshard Financial Services's NVO Position: Q1 2026 in Review

Kohmann Bosshard Financial Services sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 246 shares — an estimated $12.5K sold.

Kohmann Bosshard Financial Services first reported a position in NVO in Q4 2024 and held it in 2 quarters. The position peaked at $107K in Q4 2024. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Kohmann Bosshard Financial Services reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Kohmann Bosshard Financial Services sold 246 Novo Nordisk shares in Q1 2026, an estimated $12.5K.
  • Kohmann Bosshard Financial Services first reported a position in Novo Nordisk in Q4 2024 and held it in 2 quarters.
  • Kohmann Bosshard Financial Services's Novo Nordisk position peaked at $107K in Q4 2024.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Kohmann Bosshard Financial Services's 13F filing for Q1 2026, filed 23 Apr 2026.